Anzeige
Mehr »
Samstag, 28.06.2025 - Börsentäglich über 12.000 News
Blockbuster-Bohrergebnisse: Gold-Antimon-Fund in Nevada trifft geopolitischen Nerv
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 910292 | ISIN: FR0000038242 | Ticker-Symbol: QTL
Frankfurt
27.06.25 | 08:02
20,100 Euro
+0,50 % +0,100
1-Jahres-Chart
LUMIBIRD SA Chart 1 Jahr
5-Tage-Chart
LUMIBIRD SA 5-Tage-Chart
RealtimeGeldBriefZeit
19,10019,60027.06.

Aktuelle News zur LUMIBIRD Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiLumibird Photonics Sweden Secures Major Naval Contract For Vidar Rangefinders With Saab And Dalo23
20.05.Lumibird und Rheinmetall schließen strategische Partnerschaft für militärische Lasersysteme64
12.05.Lumibird Receives Laser Rangefinder Orders For Skyranger 30167Lannion, 12 May 2025 - 5.45pm LUMIBIRD RECEIVES LASER RANGEFINDER ORDERS FOR SKYRANGER 30 The Lumibird Group (FR0000038242 - LBIRD), European leader in laser technologies, announces that its subsidiary...
► Artikel lesen
28.04.Lumibird: Revenue Growth Of+ 12.4% In The 1st Quarter119Lannion, 28 April 2025 - 5.45pm REVENUE GROWTH OF+ 12.4% IN THE 1st QUARTER The Lumibird Group (FR0000038242 - LBIRD), European leader in laser technologies, recorded consolidated revenue growth of+...
► Artikel lesen
LUMIBIRD Aktie jetzt für 0€ handeln
21.03.Lumibird: ACCESS TO PREPARATORY DOCUMENTS FOR THE COMBINED GENERAL MEETING ON APRIL 29, 20253
11.03.Lumibird: Annual Results 2024418Lannion, 11/03/2025 - 5:45pm ANNUAL RESULTS 2024 EBITDA margin(1) of 15.9%, of which 20.6% for the Medical division and 10.8% for the Photonics divisionStrong growth in the 2nd half with 20.2% EBITDA...
► Artikel lesen
27.01.Lumibird: 2024 Sales At €207.1m (+1.7% -reported)192Lannion, 27/01/2025 - 5.45pm LUMIBIRD: 2024 SALES AT €207.1M (+1.7% -REPORTED) Medical Division: €107.7m (+4.8% on a reported basis), a recovery confirmed by a new record for billings in Q4 of €33.5m...
► Artikel lesen
24.01.Lumibird: FINANCIAL COMMUNICATIONS AGENDA1
27.11.24Lumibird: Exploratory Project To Sell The Medical Division161Lannion, November 27, 2024 - 8:00 am LUMIBIRD: EXPLORATORY PROJECT TO SELL THE MEDICAL DIVISION Following market rumours, Lumibird (FR0000038242 - LBIRD) confirms that it is currently exploring the...
► Artikel lesen
21.10.24Lumibird: Q3 Revenue - Agreement Signed To Acquire The Continuum Product Range From The Amplitude Laser Group671Lannion, October 21, 2024 - 5:55 pm Q3 REVENUEAGREEMENT SIGNED TO ACQUIRE THE CONTINUUM PRODUCT RANGE FROM THE AMPLITUDE LASER GROUP Growth upturn in Q3 for the Medical Division, stability for the...
► Artikel lesen
15.10.24Lumibird: Banks Renew Their Confidence In The Group's Strategy With Financing Of Over €100m213Lannion, October 15, 2024 - 17:45 pm LUMIBIRD: BANKS RENEW THEIR CONFIDENCE IN THE GROUP'S STRATEGY WITH FINANCING OF OVER €100M 55.2m repayable over 7 years, to reschedule existing loans50m to be...
► Artikel lesen
24.07.24Lumibird Receives New Orders From Thales510Lannion, July 24, 2024 - 17:35 LUMIBIRD RECEIVES NEW ORDERS FROM THALES The LUMIBIRD Group (FR0000038242 - LBIRD), a European leader in laser technologies, announces that Lumibird Photonics Sweden...
► Artikel lesen
22.07.24Lumibird: H1 2024 revenues349Lannion, July 22, 2024- 5:45 pm H1 2024 REVENUES Slight increase to €98m (+1%) with a base effect (H1 2023 growth of +16% vs H1 2022) 3-year target maintained for revenue growth (CAGR +8%) and profitability...
► Artikel lesen
13 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1